LogiPharma 2017 US

October 04-October 06, 2017

Westin Philadelphia, PA

Contact: 1.888.482.6012

Supply Chain Optimization to Contain Costs in an Ever Changing Healthcare Environment

07:00 AM - 08:00 AM Registration & Breakfast In The LogiLounge

08:00 AM - 08:05 AM Welcoming Remarks

Marissa Alvord, Executive Director, LogiPharma USA

img

Marissa Alvord

Executive Director
LogiPharma USA

08:05 AM - 08:25 AM Ice Breaker

Just how well do you know the City of Brotherly Love? Team up with fellow attendees for our Philadelphia Quiz Ice Breaker! Meet new connections and have a few laughs along the way as you put your Philly knowledge to the test. The winning table will enjoy a bubbly prize!

08:25 AM - 08:40 AM Chairperson’s Opening Remarks

Interested in showcasing thought leadership as Chairperson? Contact Seth Evans at 646-200-7481 or seth.evans@wbresearch.com to find out about how to get involved as emcee.

08:40 AM - 09:10 AM Fireside Chat | Understanding Emerging Global Healthcare Trends to Remain Competitive

Scott Chilson, Vice President, Customer Connectivity , Johnson & Johnson Mike Douma, Vice President, Supply Chain, AbbVie, Inc
Growth through acquisition has been the strategy of the pharma industry for years, and few new products are coming out from big pharma. As pricing comes under increased scrutiny under the new Administration, cost pressures will become even greater. How can the industry maintain margins and cut out supply cost? How can companies cost effectively become more patient centric? How can the industry control costs as novel therapies, including biologics, personalized medicine, cell and gene therapies require new supply chain strategies? Two Heads of Supply Chain will weigh in on what they’re scrutinizing and how they are preparing for the future, including:
Macro trends impacting shipping and distribution
The ‘patient of the future’ and how to meet future needs
Key opportunities to advance supply chain strategy over the next ten years
Areas of investment to remain competitive
How to ensure you remain current with disruptive technologies and innovations


img

Scott Chilson

Vice President, Customer Connectivity
Johnson & Johnson
img

Mike Douma

Vice President, Supply Chain
AbbVie, Inc

09:10 AM - 09:30 AM Revising Supply Chain Strategies to Plan for 2020 and Beyond

Mike Douma, Vice President, Supply Chain, AbbVie, Inc
Many big pharma companies are planning for a bulk of revenues to come from biologics and large molecule therapies in the next few years, which has huge implications for the supply chain. How do you stand up a biologics supply chain while building out small molecule supply chains in emerging markets given global market conditions? How can you be confident that you’ve mapped enough long-term capacity for biologics?
Find out how one supply chain leader is planning for 2020, including:
Maintaining infrastructure for small molecule production and distribution when launching products in other markets
Maximizing spend and vendor relationships on a global scale, from governance issues to oversight where there are matrixed reporting lines
Product rationalization to maximize opportunities


img

Mike Douma

Vice President, Supply Chain
AbbVie, Inc
2016 brought about significant political change on a global level that has serious implications for supply chain management. Brexit and the proposed changes by the new Administration are challenging the notion of globalization in a shift to a more nationalist approach, changing the way supply chains and businesses work. How are companies preparing for this change? What are the implications for supply chain? What needs to be in place for a supply chain to be agile to quickly respond to change? An economist, government affairs executive and supply chain leaders will discuss how these changes will impact the supply chain.
Panelists will discuss the ways in which:
Their firms are reacting to new changes
Costs are being assessed for offshoring versus reshoring
Supply chain network plans are being re-evaluated


img

Juan Fernando Forero

Vice President, Network Supply Operations, Pfizer Innovative Health
Pfizer, Inc.
img

Kevin Cook

VP Supply Chain North America
Sandoz
img

Michael Orlowski

Vice President, Supply Chain and Technical Operations
Daiichi Sankyo, Inc

10:10 AM - 10:25 AM Panel Revolution | Adapting Supply Chain Strategies in the Context of Reverse Globalization

10:25 AM - 10:45 AM Parcel and Pharma / Becoming More the ‘Norm’ for Delivering Pharmaceuticals?

Steve Williamson, Director, Solution Consulting, BluJay Solutions
Are you seeing the trend of consumers getting their pharmaceuticals via the web? Phone in? Has the trend of picking up the medications at a pharmacy or doctor’s office changed for your business? Can these changes be supported by your outbound parcel system?
Hear more about the latest in delivery, including:
Adult Signature Required
Last Mile Delivery Options
Multi Carrier
Proof Of Delivery


img

Steve Williamson

Director, Solution Consulting
BluJay Solutions

10:45 AM - 11:05 AM Voice of the Provider | Supply Chain Optimization to Keep Ahead of Current & Future Healthcare Trends

William Mosser, Vice President, Materials Management , FMOLHS
Cost containment is the top priority for all supply chain leaders in healthcare, particularly when drug costs increase each year. New standards, including global serialization rules are creating a shift in the marketplace suggesting that the industry is ready for change. William Mosser, Vice President, Materials Management, FMOL- Health System has been partnering more closely with medical device companies and is looking to work directly with pharmaceutical companies. In this session, William will draw the curtains open to shed light on current healthcare legislation and how it’s affecting providers and how IDNs are optimizing supply chain strategies.
Gain key insights including:
What financials look like within hospitals
Regulatory impacts of data requirements
Priorities for supply chain optimization
How to partner with providers to cut costs and provide better patient care


img

William Mosser

Vice President, Materials Management
FMOLHS

11:05 AM - 11:45 AM Morning Refreshment & Networking Break In The LogiLounge

New digital innovations are causing many disruptions while at the same time they bring us a whole new portfolio of possibilities. The burning question is, how will future supply chains leverage these innovations to align consumer demand and supply realities in an agile way? Are you prepared?
img

Brad Pawlowski

Managing Director, Life Sciences Supply Chain
Accenture
img

Jennifer Donatelli

Managing Director, Strategy Supply Chain
Accenture
Interested in demonstrating thought leadership facilitating a conversation with a group of supply chain leaders as a roundtable discussion host? Contact Seth Evans at 646-200-7481 or seth.evans@wbresearch.com


#1 Preparing for 2020 and Beyond, Preparing for New Revenue Streams
Mark Holder, Executive Director, Regional Supply North America, AstraZeneca

#2 Parcel and Pharma / Becoming More the ‘Norm’ for Delivering Pharmaceuticals?Steve Williamson, Director, Solution Consulting, BluJay Solutions

#3 Controlling Your Own Fate by Rotating to the New
Brad Pawlowski, Managing Director, Life Sciences Supply Chain, Accenture
Jennifer Donatelli, Managing Director, Strategy Supply Chain, Accenture

#4 Understanding Supply Chain Global Political Impact Related to Brexit and New US Administration
Erica Olson, Vice President, GMS Strategy and Business Development,GSK

#5 Best Practices to Better Manage CMO Performance, From Cost Improvements to Serialization Compliance
Eric Allen, Vice President, Sales & Marketing, Aphena Pharma Solutions
Ed Ram, Senior Director, Supply Chain, Sagent Pharmaceuticals

#6 Risk of Imports of Pharmaceuticals to the US, and Supply Chain Mitigation Strategies
Richard Codner, Director, Distribution, Merck & Co

#7 How to Account for a Range of Temperature Control Needs and Scenarios

#8 Bridging the Gap Between Commercial and Clinical Supply Chain to Best Meet the Needs of Patients


img

Mark Holder

Executive Director, Regional Supply North America
AstraZeneca
img

Steve Williamson

Director, Solution Consulting
BluJay Solutions
img

Brad Pawlowski

Managing Director, Life Sciences Supply Chain
Accenture
img

Jennifer Donatelli

Managing Director, Strategy Supply Chain
Accenture
img

Eric Allen

Vice President, Sales & Marketing
Aphena Pharma Solutions
img

Ed Ram

Senior Supply Chain Director
Sagent Pharmaceuticals
img

Richard Codner

Director, Distribution
Merck & Co

1:10 PM - 2:10 PM Lunch

Track A: Next Generation Supply Chain Planning

2:10 PM - 2:20 PM Chairperson’s Opening Remarks

Interested in showcasing thought leadership as Chairperson? Contact Seth Evans at 646-200-7481 or seth.evans@wbresearch.com to find out about how to get involved as emcee.

Track A: Next Generation Supply Chain Planning

2:20 PM - 3:00 PM Panel Discussion | Connecting Business KPIs to Advance Demand Planning

Michele Dorris, Executive Director, Supply Chain, Sandoz, Novartis Division Jen Wang, Vice President, Global Planning , Allergan, Inc.
Many companies continue to struggle with demand timing and cost competitiveness. How can you better forecast manufacturing with what sales actually does? What kinds of metrics will allow you to measure the health of your forecast?
Panelists will discuss:
How to best interface between commercial and supply planning
Opportunities from people and process perspectives to mature demand planning
“Greatest Hits” or what best practices they’ve continued from previous roles


img

Michele Dorris

Executive Director, Supply Chain
Sandoz, Novartis Division
img

Jen Wang

Vice President, Global Planning
Allergan, Inc.

Track A: Next Generation Supply Chain Planning

3:00 PM - 3:20 PM Innovation Spotlight Showcase

Over the course of 20-minutes, hear from two innovative companies showcasing the latest in demand planning and S&OP solutions during a 10-minute spotlight. To find out more about showcasing your solution, contact Seth Evans at 646-200-7481 or seth.evans@wbresearch.com

Track A: Next Generation Supply Chain Planning

3:20 PM - 3:40 PM Preparing for Launch, Improving Collaboration for a Seamless Launch

Tiffany Cavallaro, Director, Supply Chain, Amgen
Bringing new products to market is one of the most critical activities for a biopharma company and the biggest challenge is ensuring things happen on time and effectively. What are some of the innovative approaches being used to take products to market? Where does turnover from R&D, planning and operations happen? How do you get planning involved?
Find out:
How to best project manage launch readiness
Skills and competencies needed to support an agile organization
Lessons learned from generics, where speed to market is critical


img

Tiffany Cavallaro

Director, Supply Chain
Amgen

Track B: Improving Temperature Control Processes While Containing Costs

2:10 PM - 2:20 PM Chairperson’s Opening Remarks

Interested in showcasing thought leadership as Chairperson? Contact Seth Evans at 646-200-7481 or seth.evans@wbresearch.com to find out about how to get involved as emcee.

Track B: Improving Temperature Control Processes While Containing Costs

2:20 PM - 2:40 PM Case Study | Designing a Cold Chain Process to Meet the Unique Needs of Cell and Gene Therapy Treatments

Michael Trocchia, Director, Supply Chain, Novartis
Cold chain and temperature control processes are making new strides as biologics and other cutting edge therapies come to market. Cell and gene therapies are among the most innovative and exciting therapies in development and they require a completely new cold chain and supply chain strategy. Samples need to be taken from patients, treated and returned to patients and any disruptions will have serious and negative consequences for vulnerable patients. How can you ensure this process is seamless? How can this process be commercialized once therapies are approved?
Find out how to:
Design a project scheduling system to meet unique patient needs
Overcome the challenges of tracking chain of identity
Replicate this process on a larger scale


img

Michael Trocchia

Director, Supply Chain
Novartis

Track B: Improving Temperature Control Processes While Containing Costs

2:40 PM - 2:50 PM Gaining Inventory Visibility and Achieving Savings on Reusable Temperature Controlled Packaging

Kevin Lawler, Vice President, Worldwide Sales, Pelican BioThermal

img

Kevin Lawler

Vice President, Worldwide Sales
Pelican BioThermal

Track B: Improving Temperature Control Processes While Containing Costs

2:50 PM - 3:00 PM Data Driven Risk Management in Global Airfreight

Frank Cascante, Head of Business Development Americas, DHL Temperature Management Solutions /LifeConex Americas
In life sciences and healthcare, big data analytics via the deployment of business intelligence risk technology, is opening up a broad based ability by logistics operators (and their partners) within the supply chain space, to mitigate risk across the supply chains. Through the use of Lane Risk Assessments, Risk Priority Rating per Event Milestones, then developing these into Failure Mode Effect Analysis Plans, (FMEA), are creating simulation scenarios before transportation resources are committed, and opening entirely new view of what was previously effected only through trial and error of the shipments traverse through the logistics pipeline. As a result of this technological deployment of big data analysis, entirely new levels of supply chain efficiency within the temperature controlled logistics and risk amelioration are possible.

img

Frank Cascante

Head of Business Development Americas
DHL Temperature Management Solutions /LifeConex Americas

Track B: Improving Temperature Control Processes While Containing Costs

3:10 PM - 3:40 PM Working Group | Air v. Ocean, Active v. Passive, Managing Risk and Optimizing Costs

The air versus ocean debate is ongoing and many are moving to ocean freight to achieve cost savings and utilize active shipping containers. How are you utilizing a combination of both approaches to contain costs while ensuring product integrity? When should you use active versus passive? How do you mix and match shipping methods along the journey to increase economies of scale without compromising product integrity? What are companies doing to increase ocean freight? During this interactive session, you’ll discuss and work through these topics with your peers at your table, hear their successes and lessons learned to help you advance your temperature control strategy.

Supply Chain Leaders Boardroom

2:10 PM - 3:40 PM Supply Chain Leaders Boardroom

The Supply Chain Leaders Boardroom is your opportunity to connect and idea share with Heads of Supply Chain and supply chain leaders. Participation is limited to no more than 20 participants and discussion topics will include:
How to become more strategic versus tactical
Career progression and life after supply chain
What you need to do to be prepared for highly interconnected networks
Interested in a topic not listed? Share your ideas with Event Director, Marissa Alvord, marissa.alvord@wbresearch.com


3:40 PM - 4:20 PM Afternoon Refreshment & Networking Break In LogiLounge

General Session

4:20 PM - 4:40 PM Case Study | Consolidating the Supply Chain, Shifting Away from a Decentralized Model

Kevin Cook, VP Supply Chain North America, Sandoz
As cost pressures increase, companies across the industry are looking for economies of scale and cost containment through centralized supply chains and shared service models. Novartis, Alcon and Sandoz have consolidated the supply chain footprint and are working toward a 2020 savings target. Find out lessons learned and key successes in this major supply chain transformation, including:
Optimizing the number of distribution centers
How to make it work when there are competing priorities in the absence of contracts


img

Kevin Cook

VP Supply Chain North America
Sandoz

General Session

4:40 PM - 4:50 PM Innovation Spotlight: Optimizing Your Temperature Controlled Supply Chain: Leasing vs. Purchasing – What is Right For You?

Ben Vanderplas, Global Product Manager, Sonoco Thermosafe

img

Ben Vanderplas

Global Product Manager
Sonoco Thermosafe

General Session

4:50 PM - 5:10 PM Driving Lean and Operational Excellence Activities to Reduce Costs

Linzell Harris, Senior Vice President, Global Supply Chain, Teva Pharmaceuticals
Lean margins mean the need for an efficient supply chain. The continuous improvement mentality is housed in the supply chain organization, but how can you expand the reach to drive out waste?
Find out how to:
Achieve cost savings without reducing headcounts
Create a Lean culture and make the concepts stick
Drive lead times through value stream mapping
Identify non-value added activities to improve efficiencies


img

Linzell Harris

Senior Vice President, Global Supply Chain
Teva Pharmaceuticals

Creative Boardroom Part I

4:20 PM - 5:10 PM Designing a Supply Chain Staffing Model for Small to Mid-Sized Companies

Jason Cameron, Vice President, Global Supply Chain, Amicus Therapeutics Joseph Berry, Director, Supply Chain Operations, Amicus Therapeutics
Limited to 15 supply chain practitioners from manufacturers only, sign up at registration to share best practices and problem solve with peers battling similar challenges.

Understanding the skillsets and capabilities needed for smaller supply chain teams
Identifying critical skillsets that are needed now and mapping them to the future
Handling make vs. buy decisions when it comes to in-house talent and consulting


Jason Cameron

Vice President, Global Supply Chain
Amicus Therapeutics

Joseph Berry

Director, Supply Chain Operations
Amicus Therapeutics

5:10 PM - 6:10 PM LogiPharma Welcome Reception in the LogiLounge

After a day filled with keynotes, breakouts and panels take a moment to celebrate with your new friends! Join us in the LogiLounge for a chance to connect with some of the biopharma industry’s finest leaders. Now’s the time to network with peers
and clients at one of the largest and most informative supply chain meetings in the industry.

6:10 PM - 11:59 PM Conclusion Of Day One

Live Chat Software